Company / R&D per Share
Mirum Pharmaceuticals, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.85
FY2025
5-year range
$2.74 / $4.30
FY2021-FY2025
Trend
+28.0%
vs FY2024
Sector context
#53 of 208
Health Care
What the data says
Mirum Pharmaceuticals, Inc.'s r&d per share of $3.85 is higher than 75% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 8 years, ranging from $2.59 in FY2018 to $4.30 in FY2022.
Based on SEC 10-K filings.
3.85 in FY2025 with a 5-year CAGR of +3.6%.
Improved from $2.78 to $3.85 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -3.6%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 208This company $3.85 Sector average $12.19
▼
-68.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 28.0% year-over-year.
- Ranks #53 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.85 | +28.0% |
| FY2024 | $3.01 | +8.4% |
| FY2023 | $2.78 | -35.4% |
| FY2022 | $4.30 | +56.8% |
| FY2021 | $2.74 | -15.2% |
| FY2020 | $3.23 | -13.7% |
| FY2019 | $3.74 | +44.4% |
| FY2018 | $2.59 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026